Archived Bylaws HPA Bylaws Bylaws Schedule A - Code of Ethics Code of Ethics - Summary of Standards Code of Ethics - Detailed Conflict of Interest Standards Model for Ethical Decision Making Patient Relations Program Standard Pharmacy Oath Schedule B - Electoral Districts Schedule C - Recognized Education Programs Schedule D - Fee Schedule Schedule E - Tariff of Costs Schedule F - Standards of Practice Part 1 - Community Pharmacy Part 2 - Hospital Pharmacy Part 3 - Residential Care Facilities and Homes Part 4 - Drug Administration by Injection and Intranasal Route Part 5 - Dispensing Drugs for the Purpose of Medical Assistance in Dying Part 6 - Telepharmacy Part 7 - Indigenous Cultural Safety, Humility, and Anti-racism Practice Standard Part 8 - Making a Diagnosis and Prescribing Part 9 - Ordering, Receiving, and Interpreting Laboratory Tests Standards, Limits and Conditions Schedule G - Maximum Fees of the Freedom of Information and Protection of Privacy Act PODSA Bylaws Bylaws Schedule A - Fee Schedule Schedule B - Exemptions to Act Schedule F - Telepharmacy and Community Licenced Sites Schedule G - Telepharmacy Staff Exempted Sites Schedule H - Telepharmacy Rural and Remote Communities Archived Professional Practice Policies and Guides Professional Practice Policies (Full Document) GENERAL PHARMACY PRACTICE PPP-3 Pharmacy References PPP-58 Adapting a Prescription PPP-59 Pharmacy Equipment PPP-60 Professional Liability Insurance PPP-64 Guidelines to Pharmacy Compounding PPP-65 Narcotic Counts and Reconciliations PPP-68 Cold Chain Management PPP-70 Making a Diagnosis and Prescribing - Regulatory Education Module PPP-73 Validate Identification and Verify College Registration Status for New and Existing Registrant Staff PPP-75 Patient Identification PPP-76 Criminal Record History Vendor PPP-77 Signage within the Pharmacy (Expectations of Care Poster) COMMUNITY PHARMACY PPP-15 Controlled Drug Substances Signing Authorizations PPP-24 Depot Shipments of Prescriptions PPP-31 Emergency Supply for Continuity of Care PPP-43 Automated Pharmacy Dispensing System PPP-46 Temporary Pharmacy Closures PPP-50 Centralized Prescription Processing PPP-54 Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings PPP-64 Guidelines to Pharmacy Compounding PPP-66 Opioid Agonist Treatment PPP-67 Injectable Opioid Agonist Treatment PPP-69 Community Pharmacy Manager Education PPP-71 Delivery of Opioid Agonist Treatment PPP-74 Community Pharmacy and Telepharmacy Security PPP-76 Criminal Record History Vendor PPP-77 Signage within the Pharmacy (Expectations of Care Poster) HOSPITAL PHARMACY PPP-15 Narcotic and Controlled Drug Signing Authorizations PPP-27 Registration Requirements for Pharm.D. Program Students PPP-43 Automated Pharmacy Dispensing System PPP-56 Standards for Pharmacy Assistant Verification of Non-Sterile Products in Hospital Pharmacy Practice PPP-57 Standards for Pharmacy Assistant Verification of Sterile Products in Hospital Pharmacy Practice PPP-63 Hospital Pharmacist Role with Respect to Drug Distribution Systems, Drug Administration Devices, Products and Services PPP-64 Guidelines to Pharmacy Compounding PPP-76 Criminal Record History Vendor PPP-77 Signage within the Pharmacy (Expectations of Care Poster) Guides and additional Resources PPP-58 Adapting a Prescription: Additional Resources PPP-66 Opioid Agonist Treatment: PPP-66 Policy Guide: Buprenorphine/Naloxone Maintenance Treatment (2018) PPP-66 Policy Guide: Methadone Maintenance Treatment (2013) PPP-66 Policy Guide: Slow Release Oral Morphine Maintenance (SROM) Treatment (2018) PPP-67 Injectable Opioid Agonist Treatment PPP-67 Policy Guide: Injectable Hydromorphone Maintenance Treatment (2018)
Share
